| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |